Literature DB >> 7030959

Correlation between the production of extracellular substances by type III group B streptococcal strains and virulence in a mouse model.

D L Durham, S J Mattingly, T I Doran, T W Milligan, D C Straus.   

Abstract

Twelve strains of serotype III group B streptococci (8 isolated from cases of neonatal disease, 3 isolated from asymptomatically colonized infants, and 1 laboratory reference strain) were examined for the vitro production of three potential extracellular virulence products: type-specific antigen, neuraminidase, and protease. In addition, virulence in a mouse model, expressed as 50% lethal dose, was determined for the 12 strains to determine whether a relationship existed between the production of any of the three extracellular products and virulence. Only production of extracellular type-specific antigen showed a correlation with virulence in the mouse model. The high producers of extracellular type-specific antigen were an average of 166-fold more virulent for mice than low producers of the same component. There was no correlation between virulence and either neuraminidase or protease production, nor was there a correlation between either of these two extracellular products and the levels of extracellular type-specific antigen. When levels of group B streptococci of each type (a high and low producer of extracellular type-specific antigen) in organs of infected mice were examined, comparable levels of organisms were found in the brain, spleen, and lungs of mice near death regardless of the initial inoculum. However, the high producer of extracellular type-specific antigen caused death in mice with a 2 to 3 log lower inoculum than the low producer, suggesting that these strains may be more invasive.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7030959      PMCID: PMC350887          DOI: 10.1128/iai.34.2.448-454.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Further studies on generation of macrophages in in vitro cultures of mouse spleen cells and its inhibition by the capsular polysaccharide of Klebsiella pneumoniae.

Authors:  T Yokochi; I Nakashima; N Kato
Journal:  Microbiol Immunol       Date:  1979       Impact factor: 1.955

2.  Effect of capsular polysaccharide of Klebsiella pneumoniae on the differentiation and functional capacity of macrophages cultured in vitro.

Authors:  T Yokochi; I Nakashima; N Kato
Journal:  Microbiol Immunol       Date:  1977-10-20       Impact factor: 1.955

3.  Growth and amino acid requirements of various strains of group B streptococci.

Authors:  T W Milligan; T I Doran; D C Straus; S J Mattingly
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

Review 4.  Summary of the workshop on perinatal infections due to group B Streptococcus.

Authors: 
Journal:  J Infect Dis       Date:  1977-07       Impact factor: 5.226

5.  Distribution and serological specificity of sialidase produced by various groups of streptococci.

Authors:  S Hayano; A Tanaka; Y Okuyama
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

6.  Detection of group B streptococcal antibodies in human sera by radioimmunoassay: concentrations of type-specific antibodies in sera of adults and infants infected with group B streptococci.

Authors:  H W Wilkinson
Journal:  J Clin Microbiol       Date:  1978-02       Impact factor: 5.948

7.  Correlation of circulating capsular polysaccharide with bacteremia in pneumococcal pneumonia.

Authors:  G E Kenny; B B Wentworth; R P Beasley; H M Foy
Journal:  Infect Immun       Date:  1972-10       Impact factor: 3.441

8.  Soluble group- and type-specific antigens from type III group B Streptococcus.

Authors:  R B Carey; T K Eisenstein; G D Shockman; T F Greber; R M Swenson
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

9.  Countercurrent immunoelectrophoresis in the evaluation of infants with group B streptococcal disease.

Authors:  C J Baker; B J Webb; C V Jackson; M S Edwards
Journal:  Pediatrics       Date:  1980-06       Impact factor: 7.124

10.  THE ELABORATION OF SPECIFIC SOLUBLE SUBSTANCE BY PNEUMOCOCCUS DURING GROWTH.

Authors:  A R Dochez; O T Avery
Journal:  J Exp Med       Date:  1917-10-01       Impact factor: 14.307

View more
  11 in total

1.  Biosynthetic capacity for type-specific antigen synthesis determines the virulence of serotype III strains of group B streptococci.

Authors:  M K Yeung; S J Mattingly
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

2.  Lobar pneumonia in rats produced by clinical isolates of Klebsiella pneumoniae.

Authors:  P Domenico; W G Johanson; D C Straus
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

3.  Association of type- and group-specific antigens with the cell wall of serotype III group B streptococcus.

Authors:  T I Doran; S J Mattingly
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

4.  Type-specific capsular antigen is associated with virulence in late-onset group B Streptococcal type III disease.

Authors:  M E Klegerman; K M Boyer; C K Papierniak; L Levine; S P Gotoff
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

5.  Opsonin-independent phagocytosis of group B streptococci: role of complement receptor type three.

Authors:  J M Antal; J V Cunningham; K J Goodrum
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

6.  Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease.

Authors:  J M Musser; S J Mattingly; R Quentin; A Goudeau; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

7.  In vitro method to differentiate isolates of type III Streptococcus agalactiae from symptomatic and asymptomatic patients.

Authors:  J J Maurer; S J Mattingly
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

8.  Molecular analysis of lipoteichoic acid from Streptococcus agalactiae.

Authors:  J J Maurer; S J Mattingly
Journal:  J Bacteriol       Date:  1991-01       Impact factor: 3.490

9.  Cell growth rate regulates expression of group B Streptococcus type III capsular polysaccharide.

Authors:  L C Paoletti; R A Ross; K D Johnson
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

10.  Virulence of human and bovine isolates of group B streptococci (types Ia and III) in experimental pregnant mouse models.

Authors:  B Poutrel; J Dore
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.